World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
80
Citations
35293
World Ranking
1134
National Ranking
514

Overview

Scott M. Hammer was affiliated with Columbia University in the United States and contributed to research primarily in the fields of Medicine and Immunology and Microbiology. Their work focused heavily on Infectious Diseases, particularly those related to HIV/AIDS, as well as Virology, Immunology, and Emergency Medicine. The research addressed multiple aspects of HIV/AIDS, including drug development, treatment strategies, immune cell function, and complications associated with HIV.

Their main research topics included:

  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • Immune Cell Function and Interaction
  • Drug-Induced Adverse Reactions
  • LGBTQ Health, Identity, and Policy

Scott M. Hammer published several papers, with notable recent works including:

  • "Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society-USA Panel," 2020, UNC Libraries
  • "A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less," 2020, UNC Libraries

Additional papers by Hammer's frequent collaborators appeared in similar venues, such as UNC Libraries.

Frequent co-authors included:

  • Joseph J. Eron (3 publications)
  • Peter Reiss (2 publications)
  • Melanie Thompson (2 publications)
  • Pedro Cahn (2 publications)
  • Margaret A. Fischl (2 publications)

The primary publication venues for this researcher were:

  • UNC Libraries (4 publications)
  • EBioMedicine (1 publication)
  • Transgender Health (1 publication)

Best Publications

  • A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

    Scott M. Hammer;Kathleen E. Squires;Michael D. Hughes;Michael D. Hughes;Janet M. Grimes

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • The Challenge of HIV-1 Subtype Diversity

    Barbara S. Taylor;Magdalena E. Sobieszczyk;Francine E. McCutchan;Scott M. Hammer

  • Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

    Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Treatment for adult HIV infection.

    Yeni Pg;Hammer Sm;Hirsch Ms;Saag Ms

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

    Sarah Palmer;Mary Kearney;Frank Maldarelli;Elias K. Halvas

  • Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.

    Sotirios Tsiodras;Christos Mantzoros;Christos Mantzoros;Scott Hammer;Matthew Samore

Frequent Co-Authors

David Katzenstein
David Katzenstein Stanford University
Margaret A. Fischl
Margaret A. Fischl University of Miami
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Douglas D. Richman
Douglas D. Richman University of California, San Diego
M. Juliana McElrath
M. Juliana McElrath University of Washington
Robert T. Schooley
Robert T. Schooley University of California, San Diego
John W. Mellors
John W. Mellors University of Pittsburgh
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Stefano Vella
Stefano Vella Istituto Superiore di Sanità

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond traditional microbiology, pursuing certifications and degrees in health information management and medical coding offers promising career opportunities. One popular credential is the certified professional coder certification, which equips professionals with essential skills to accurately code medical records and improve healthcare data accuracy.

Entry-level positions in this field can provide competitive compensation, as seen with the health information management salary entry-level data, which highlights fast-growing job prospects. To ensure quality education, enrolling in the best online cahiim accredited health information management degree programs is crucial. These programs are recognized for meeting rigorous standards and preparing graduates for certification exams.

For those looking to enter the workforce quickly, accredited fast medical billing and coding certificate online options provide accelerated pathways into medical coding roles. Integrating these qualifications with a background in microbiology can open diverse career pathways within healthcare tech, informatics, and administration.

Best Scientists Citing Scott M. Hammer